{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Uncommon Histopathological Variants of Malignant Melanoma - Part 2

Activity Steps

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Analyze different types of melanocytic tumors regarding architectural, cytomorphological, and immunohistochemical features.
  2. Assess the histopathological pattern of different types of melanoma with particular regard to specific variants characterized either by presence of peculiar cell types (eg, balloon cells, multinucleated cells, signet-ring cells, etc.), by unconventional morphology (eg, follicular melanoma, bullous melanoma, small melanoma, etc.), or by stromal changes (eg, desmoplasia).
  3. Distinguish between several melanoma variants with peculiar structural features and recognize challenges related to measurement of tumor thickness.
Price: $15.00

Credits:

  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: AJD0519
Published: May 2019
Expires: 1/1/2026
Required Passing Score: 4/5 (80%)
Authors: Andrea Saggini, MD, Carlo Cota, MD, Viviana Lora, MD, Heinz Kutzner, MD, Arno Rütten, MD, Omar Sangüeza, MD, Luis Requena, MD, and Lorenzo Cerroni, MD
Topics: Melanoma